WATSON AND UNIMED PHARMACEUTICALS, INC. SETTLE LAWSUIT OVER ANDROGEL TESTOSTERONE GEL

Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced that it has reached a settlement with Unimed Pharmaceuticals, Inc., a wholly owned subsidiary of Solvay Pharmaceuticals, Inc., and Laboratories Besins Iscovesco on outstanding patent litigation related to AndroGel 1% (testosterone gel) CIII, a topical testosterone replacement gel.

Drug Newswire (http://www.drugnewswire.com/5953/)